Eyes and vision, Guidance

Applied filters

Care Setting (2)
- Paediatrics and neonates (2)
Guidance (77)
- Administering (1)
- Advanced therapy medicinal products (16)
- Excipients (1)
- In-use stability (1)
- Safety in Breastfeeding (53)
- Stability in dosette boxes (22)
- Stability outside the fridge (18)
- Supply (2)
Medicine (61)
- Acetazolamide (2)
- Acetylcysteine (1)
- Aciclovir (1)
- Adalimumab (1)
- Aflibercept (1)
- Atropine (1)
- Azelastine (1)
- Azithromycin (1)
- Betamethasone (1)
- Bevacizumab (1)
- Bimatoprost (1)
- Cefuroxime (1)
- Chloramphenicol (3)
- Ciclosporin (1)
- Ciprofloxacin (1)
- Cyclopentolate (1)
- Dexamethasone (1)
- Diclofenac sodium (1)
- Eculizumab (1)
- Fluocinolone acetonide (1)
- Flurbiprofen (1)
- Fusidic acid (1)
- Ganciclovir (1)
- Gentamicin (1)
- Ketotifen (1)
- Latanoprost (1)
- Latanoprost + Timolol (1)
- Levobunolol (1)
- Levofloxacin (1)
- Lidocaine (1)
- Liquid paraffin (1)
- Macrogol 3350 (1)
- Mercaptamine (1)
- Mitomycin (2)
- Moxifloxacin (1)
- Nedocromil (1)
- Ocriplasmin (1)
- Ofloxacin (1)
- Pegaptanib (1)
- Phenylephrine (1)
- Pilocarpine (1)
- Povidone (1)
- Proxymetacaine (1)
- Ranibizumab (1)
- Sirolimus (1)
- Sodium chloride (1)
- Sodium cromoglicate (1)
- Sodium hyaluronate (1)
- Tafluprost (1)
- Tetracaine (1)
- Timolol (1)
- Tobramycin (1)
- Triamcinolone acetonide (1)
- Varenicline (1)
- Voretigene neparvovec (1)
- Yellow soft paraffin (1)
Planning (44)
- Biosimilars (4)
- New Medicines (33)
  - CCG commissioned new medicines (15)
  - NHS England commissioned new medicines (22)
  - Pre-registration new medicines (UK/EU) (3)
- Patent expiries (21)
Specialty (77)
- Allergy and immunology (2)
- Anaesthesia and pain (5)
- Cancers (7)
- Cardiovascular system disorders (4)
- Ear, nose and throat disorders (11)
- Endocrine system disorders (2)
- Eyes and vision (77)
- Gastrointestinal disorders (5)
- Haematological disorders (3)
- Infection and infectious diseases (13)
- Mental health and illness (1)
- Musculo-skeletal disorders (7)
- Nutritional and metabolic disorders (3)
- Obstetrics and gynaecology (1)
- Renal and urologic disorders (1)
- Respiratory disorders (6)
- Skin disorders (11)

Using chloramphenicol eye products in children under 2 years

29 April 2021Boron or borates present in chloramphenicol eye drops could affect safety when used in children under 2 years due to a potential effect on future fertility

Guidance

SPS Advice Note: Interim position statement 3; BD Field Safety Notice (FSN) and intraocular injections (BD and other syringes)

18 February 2021Advice following the issue of the BD Urgent Field Safety Notice MPS-18-1209 regarding the use of BD and BBraun (Medline) syringes for intraocular injections.